Editorial on the original article entitled “Changes in diabetes related complications in the United States, 1990 2010” published in the New England Journal of Medicine on April 17, 2014

UK Prospective Diabetes Study Group: Effect of intensive blood- glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS

ADA: stands for American Diabetes Association; CGM: is Continuous Glucose Monitoring; CHD: is Coronary Heart Disease; DCCT: is the Diabetes Control and Complications Trial; ESRD:

Getting control of your blood glucose levels with healthy lifestyle changes, insulin, and/or medications is the best way to prevent or slow down diabetes-related complications,

The findings of the Diabetes Control and Complications Trial (DCCT) and the United Kingdom Prospective Diabetes Study (UKPDS) clearly showed that intensive control of

Abbreviations: BG, blood glucose; BR, buffered regular insulin; CSII, continuous subcutaneous insulin infusion; DCCT, Diabetes Control and Complications Trial; IAsp, insulin

The Diabetes Control and Complications Trial (DCCT) [4], United Kingdom Prospective Dia- betes Study (UKPDS) [5] and Japan Kumamoto Study [6] which focused on enhanced glucose

6 The Diabetes Control and Complications Trial (DCCT), the United Kingdom Prospective Diabetes Study (UKPDS) showed hyperglycemia is a risk factor for macrovascular

The Diabetes Control and Complications Trial (DCCT) and the United Kingdom Prospective Diabetes Study (UKPDS) have shown definitively that intensive diabetes therapy can